CellCept

CellCept is the brand name for the medication mycophenolate mofetil. It is an immunosuppressant drug used to prevent the body from rejecting a transplanted organ, such as a kidney, liver, or heart. It works by suppressing the immune system's ability to attack the new organ. CellCept is also used to treat certain autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. Examples include lupus nephritis and inflammatory bowel disease.

The active ingredient, mycophenolate mofetil, is converted into mycophenolic acid in the body. This active form inhibits an enzyme essential for the proliferation of lymphocytes, a type of white blood cell that plays a key role in immune responses. By reducing the number and activity of these lymphocytes, CellCept effectively dampens the immune system's attack on foreign or self-antigens.

CellCept is typically administered orally as a capsule or tablet, or intravenously. The dosage and duration of treatment depend on the specific medical condition being treated and the patient's response. It is often prescribed as part of a combination therapy with other immunosuppressive drugs.

Common side effects of CellCept can include gastrointestinal issues like diarrhea, nausea, and vomiting. Other potential side effects include headaches, tremors, and an increased risk of infections due to the suppression of the immune system. Patients taking CellCept require regular monitoring by a healthcare professional to manage potential side effects and ensure the effectiveness of the treatment. It is crucial to discuss any concerns or other medications with a doctor before starting CellCept.